FBXW7 and colorectal carcinoma: In CRC cell models, FBXW7 downregulation increases the activity of NADPH oxidase 1 (Nox1) and mTOR, leading to resistance to paclitaxel and cisplatin (Huang and Long, 2023; Wang HP.